Remodelling and adverse remodelling in CAD

S Brenner1, G Ertl

  • 1Department of Internal Medicine I/Comprehensive Heart Failure Center, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080, Würzburg, Germany.

Herz
|August 30, 2012
PubMed

Insights

Cardiac remodelling is the heart

Area of Science:

  • Cardiovascular Research
  • Cardiac Pathophysiology

Background:

  • Cardiac remodelling is a key response to heart injury or overload.
  • Maladaptive cardiac remodelling can lead to heart failure and sudden cardiac death.
  • Ischemic injury in coronary artery disease alters heart structure and function.

Purpose of the Study:

  • To summarize the current understanding of cardiac remodelling in response to ischemic injury.
  • To highlight therapeutic strategies for reversing adverse cardiac remodelling.
  • To identify future targets for preventing and reversing ischemic remodelling.

Main Methods:

  • Review of existing literature on cardiac remodelling.
  • Analysis of cellular, extracellular, molecular, and genetic alterations in ischemic heart disease.
  • Evaluation of therapeutic interventions for adverse remodelling.

Main Results:

  • Adverse cardiac remodelling leads to heart failure and sudden cardiac death.
  • Ischemic injury causes significant changes in heart architecture and contractility.
  • Therapeutic concepts have been developed, showing potential for reversing remodelling.

Conclusions:

  • Understanding the mechanisms of ischemic remodelling is crucial for developing new therapies.
  • Further research into cellular and molecular pathways can reveal novel therapeutic targets.
  • Reversal of adverse remodelling is achievable and a key goal in treating heart disease.